ricin
toxin
plantderiv
ribosomeinactiv
protein
rapidli
clear
circul
kupffer
cell
kc
liver
sinusoid
endotheli
cell
lsec
fatal
consequ
rather
inactiv
ricin
evad
normal
degrad
pathway
kill
kc
lsec
remark
effici
uptak
ricin
special
cell
type
liver
occur
parallel
rout
lactosesensit
pathway
mediat
ricin
galactosenacetylgalactosaminespecif
lectin
subunit
rtb
mannosesensit
pathway
mediat
mannos
receptor
mr
ctype
lectin
capabl
recogn
mannosesid
chain
display
ricin
rta
b
subunit
report
investig
capac
collect
ricinspecif
mous
mab
camelid
singledomain
v
h
h
antibodi
protect
kc
lsec
ricininduc
kill
case
kc
individu
mab
rta
rtb
afford
near
complet
protect
ricin
ex
vivo
vivo
challeng
studi
contrast
individu
mab
v
h
hs
afford
littl
even
protect
lsec
ricininduc
death
complet
protect
lsec
achiev
mab
v
h
h
cocktail
effect
mixtur
target
rta
rtb
simultan
although
exact
mechan
protect
lsec
remain
unknown
evid
indic
ab
cocktail
exert
effect
mannosesensit
uptak
pathway
without
need
fc
receptor
involv
addit
advanc
understand
toxin
small
immun
complex
process
kc
lsec
studi
import
implic
develop
abbas
therapi
design
prevent
treat
ricin
exposur
toxin
weapon
death
pathway
addit
exogen
lactos
inhibit
rtbmediat
attach
host
cell
pathway
refer
lactosesensit
pathway
ricin
also
gain
entri
certain
cell
type
mannosesensit
pathway
first
describ
bone
marrowderiv
macrophag
bdmc
later
shown
exist
kupffer
cell
kc
liver
sinusoid
endotheli
cell
lsec
ricin
mannosyl
differ
asparagin
residu
rta
posit
rtb
posit
number
studi
implic
mannos
receptor
mr
respons
ricin
uptak
bdmc
kc
lsec
although
studi
conduct
year
full
suit
ctype
lectin
ctl
role
pathogen
recognit
discov
nonetheless
mannosesensit
pathway
highli
effici
rout
ricin
enter
kill
kc
lsec
due
part
increas
rate
intern
compar
lactosesensit
uptak
pathway
report
sought
revisit
sensit
kc
lsec
ricin
light
effort
develop
mabbas
therapi
prophylact
ricin
exposur
exampl
recent
demonstr
iv
deliveri
singl
mab
direct
rta
abl
rescu
rhesu
macaqu
lethal
dose
aerosol
challeng
administ
within
h
window
model
ricin
intox
larg
restrict
lung
littl
system
involv
contrast
follow
inject
ricin
home
liver
concentr
kc
lsec
roch
ricin
toxin
ricinu
communi
agglutinin
ii
purchas
vector
laboratori
burlingam
ca
dialyz
remov
sodium
azid
describ
nativ
rta
r
communi
seed
obtain
bei
resourc
catalog
manassa
va
hepe
buffer
consist
gl
kcl
gl
nacl
gl
na
hpo
mab
use
studi
shown
supplement
tabl
antibodi
core
facil
boston
murin
mab
rta
rtb
previous
describ
v
h
hs
rta
rtb
also
describ
except
manuscript
prepar
liver
perfus
perform
femal
swiss
webster
mice
cell
bead
incub
min
c
dark
cell
wash
twice
ml
mac
buffer
resuspend
ml
mac
buffer
cell
separ
use
minimac
tm
kit
miltenyi
biotec
presenc
magnet
field
column
hydrat
ml
mac
buffer
cell
suspens
ad
column
rins
ml
mac
buffer
elut
neg
select
cell
collect
conic
tube
posit
select
cell
retriev
remov
column
magnet
field
ad
ml
mac
buffer
plung
conic
tube
cell
seed
collagenco
plate
imag
gather
phase
contrast
microscop
white
flatbottom
plate
coat
type
rat
tail
collagen
mgml
thermo
fisher
scientif
dilut
pb
ricin
toxin
dose
optim
lsec
cell
seed
cellsml
kc
seed
cellsml
cell
treat
ricin
dilut
plate
wash
probe
hrpconjug
antihi
tag
r
system
min
develop
inhibit
assay
serial
dilut
mab
start
separ
combin
mix
recombin
mous
mr
incub
h
rt
appli
microtit
plate
coat
ricin
describ
mice
challeng
ip
iv
ricin
toxin
pb
premix
total
mab
control
includ
mice
treat
sole
ricin
toxin
pb
h
liver
perfus
cell
separ
kclsec
mixtur
use
densiti
gradient
centrifug
describ
flow
cytometri
perform
mixtur
assess
kc
deplet
treatment
group
experi
liver
spleen
harvest
analysi
use
immunohistochemistri
ihc
tissu
immers
allow
fix
buffer
formalin
statist
analysi
carri
graphpad
prism
graphpad
softwar
san
diego
ca
visual
perform
graphpad
prism
r
use
ggtheme
packag
specif
detail
analysi
found
respect
figur
legend
studi
rat
mice
indic
kc
lsec
extrem
vulner
effect
ricin
toxin
better
understand
interact
ricin
toxin
cell
type
role
antibodi
may
play
protect
sought
establish
ex
vivo
model
primari
mous
kc
lsec
depict
versal
marker
cell
type
enabl
posit
select
although
numer
studi
report
use
magnet
microbead
lsec
select
strategi
captur
cell
subset
reason
reli
neg
select
enrich
lsec
subset
assess
rel
enrich
primari
cell
popul
kc
lsec
pool
triplestain
antibodi
specif
subject
flow
cytometri
isol
purif
protocol
yield
positivelyselect
kc
enrich
base
express
tabl
supplement
fig
kc
also
posit
data
shown
averag
kc
yield
per
mous
liver
cell
viabil
tabl
supplement
fig
lsec
pool
consist
subpopul
vari
express
level
hi
tabl
supplement
fig
lsec
popul
describ
previous
rat
subset
hepat
stellat
cell
hsc
vascular
endotheli
cell
step
liver
tissu
subject
retrograd
perfus
follow
low
speed
centrifug
remov
hepatocyt
rbc
lyse
ammonium
chlorid
remain
cell
mixtur
subject
sucros
densiti
gradient
centrifug
step
kclsec
popul
partit
collect
mix
antibodyco
magnet
bead
kc
posit
select
magnet
separ
wherea
lsec
enrich
flow
rel
enrich
viabil
primari
kc
lsec
determin
flow
cytometri
phase
contrast
microscopi
next
examin
capac
ricinspecif
mab
protect
kc
ricin
toxic
ex
vivo
previous
describ
collec
tabl
mechan
toxin
neutral
may
differ
depend
epitop
specif
rtaspecif
mab
epitop
cluster
ii
readili
neutral
ricin
cell
ic
fig
mab
also
protect
kc
ricin
toxin
although
much
less
effect
cell
assay
fig
moreov
toxinneutr
activ
plateau
kc
even
high
mab
concentr
also
afford
degre
toxinneutr
activ
kc
fig
addit
individu
antirtb
antibodi
abl
partial
protect
kc
ricin
less
effect
cytotox
assay
supplement
fig
comparison
purpos
overal
toxinneutr
activ
mab
test
kc
assay
plot
area
curv
auc
fig
plot
illustr
superior
neutral
activ
mab
assay
compar
kc
assay
result
ex
vivo
studi
prompt
us
examin
degre
individu
antiricin
mab
abl
protect
kc
vivo
chose
antirta
antirtb
studi
repres
potent
class
toxinneutr
mab
next
examin
sensit
lsec
ricin
shown
tabl
toxinneutr
activ
quadrival
mixtur
prove
nearli
potent
inactiv
ricin
mab
cocktail
fig
thu
cooccup
key
neutral
epitop
rta
rather
agglutin
fcrmediat
uptak
like
respons
protect
lsec
effect
ricin
tabl
fig
neither
individu
antirtb
mab
fig
individu
v
h
hs
data
shown
demonstr
capac
neutral
ricin
lsec
assay
mixtur
combin
moder
toxinneutr
activ
fig
next
obviou
line
investig
examin
toxinneutr
activ
pair
antirta
antirtb
mab
gener
differ
antirta
antirtb
mab
combin
use
antirtaantirtb
cocktail
demonstr
remark
potent
toxinneutr
activ
evidenc
ic
valu
fig
fact
toxinneutr
profil
essenti
superimpos
indic
equal
potenc
achiev
irrespect
differ
epitop
target
rta
ie
cluster
ii
rtb
ie
domain
also
test
potenc
differ
pair
antirtaantirtb
v
h
hs
singl
chain
antibodi
two
differ
v
h
h
pair
demonstr
potent
toxinneutr
activ
although
extent
observ
mab
fig
nonetheless
activ
associ
v
h
h
pair
much
greater
addit
effect
lsec
seed
microtit
plate
challeng
ricin
toxin
incub
pair
antirta
antirtb
mab
panel
v
h
hs
panel
b
rta
rtb
data
point
repres
averag
correspond
standard
deviat
independ
experi
indic
target
ricin
subunit
simultan
result
synergist
activ
therefor
effect
mean
protect
lsec
ricin
hypothes
observ
synergi
antirta
antirtb
mab
lsec
cytotox
assay
might
explain
mab
act
differ
ricin
uptak
pathway
base
literatur
postul
antirtb
mab
block
lactosedepend
uptak
pathway
wherea
antirta
mab
interfer
mannandepend
pathway
test
hypothesi
individu
mab
mix
lactos
block
rtbmediat
uptak
mannan
block
mr
ctl
uptak
test
abil
protect
lsec
ricin
challeng
found
neutral
activ
antirta
mab
significantli
enhanc
addit
lactos
mannan
fig
exampl
lsec
viabil
presenc
ricin
wherea
addit
lactos
result
viabil
observ
mab
direct
epitop
cluster
ii
epitop
cluster
iii
overal
result
consist
antirta
mab
block
ricin
uptak
unexpectedli
toxinneutr
activ
antirtb
mab
also
enhanc
lactos
exampl
addit
lactos
enhanc
activ
viabil
viabil
addit
mannan
enhanc
neutral
activ
viabil
fig
toxinneutr
activ
also
enhanc
lactos
mannan
although
total
lsec
viabil
never
exceed
result
suggest
antirtb
mab
may
also
interfer
ricin
uptak
via
mr
pathway
lactosedepend
uptak
pathway
postul
fact
plu
lactos
much
effect
satur
amount
mannan
plu
lactos
protect
lsec
ricin
intox
indic
mab
effector
function
mimick
mannan
postul
plausibl
explan
simpli
bind
affin
exampl
bind
ricin
subnanomolar
affin
would
expect
stay
associ
ricin
follow
endocytosi
wherea
mannan
micromolar
affin
mr
would
expect
serv
examin
possibl
antirta
antirtb
mab
interfer
toxinmr
interact
establish
solid
phase
bind
assay
immobil
ricin
toxin
probe
recombin
mous
mr
interact
mr
immobil
ricin
inhibit
mannan
dosedepend
manner
fig
high
concentr
combin
partial
inhibit
reduct
bind
mr
ricin
also
affect
mrricin
interact
lesser
extent
although
unclear
whether
reduct
bind
account
observ
effect
mab
toxinneutr
activ
also
establish
bind
assay
ricin
lsectin
anoth
ctl
enrich
liver
recogn
glcnacman
residu
like
rta
rtb
lsectin
recogn
immobil
ricin
mannosedepend
manner
although
neither
particularli
effect
block
interact
fig
collect
result
suggest
protect
lsec
ricin
toxin
mechan
interf
initi
recognit
ricin
mr
anoth
ctl
receptor
lsectin
rivax
recombin
rta
subunit
vaccin
shown
elicit
immun
ricin
mice
nonhuman
primat
also
safe
human
administ
intramuscularli
therefor
wish
examin
whether
antirivax
antisera
abl
protect
kc
lsec
ex
vivo
ricin
incub
serial
dilut
antisera
rivax
vaccin
mice
appli
kc
lsec
found
antiserum
similar
ic
titer
eg
kc
lsec
consist
roughli
equal
degre
protect
supplement
fig
result
may
explain
part
rel
efficaci
rivax
vaccin
ricin
intox
liver
play
essenti
role
detoxif
clearanc
xenobiot
circul
nonparenchym
cell
also
function
immun
surveil
uptak
sic
report
investig
capac
antirta
antirtb
mab
individu
combin
protect
primari
mous
kc
lsec
ricin
toxininduc
death
studi
motiv
fact
cargo
destin
degrad
via
lysosom
proteolyt
process
load
onto
major
histocompat
complex
ricin
evad
fate
follow
uptak
mr
anoth
ctl
unknown
evid
ricin
pass
acid
compart
follow
uptak
via
mannosesensit
pathway
ricin
known
mechan
breach
endocyt
membran
similarli
ricinmab
complex
gener
studi
would
expect
taken
lsec
way
fc
fc
inhibitori
fcreceptor
primarili
express
lsec
secondarili
kc
largest
contributor
clearanc
sic
circul
although
fc
riib
would
abl
intern
onetoon
toxinab
complex
eg
would
predict
engag
ricin
decor
mab
eg
rout
degrad
whether
fc
riib
play
role
clearanc
ricin
immun
complex
vivo
remain
determin
am
hypersensit
effect
ricin
possibl
due
high
level
mr
express
success
studi
current
studi
prompt
us
gener
human
version
goal
test
combin
human
rhesu
macaqu
model
one
limit
studi
restrict
examin
liver
lsec
kc
essenti
ignor
effect
ricin
ricin
may
hepat
cellular
inflamm
physiolog
exampl
roch
colleagu
demonstr
mice
hepat
inflamm
patholog
follow
ricin
exposur
includ
influx
neutrophil
chemokin
express
eg
fibrin
deposit
red
blood
cell
congest
hepat
parenchyma
glycogen
deplet
